Daiken Medical Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024
August 01, 2023 at 02:00 am EDT
Share
Daiken Medical Co., Ltd. provided consolidated earnings guidance for the Six months ending September 30, 2023 and full year ending March 31, 2024. For the period, the company expects net sales of JPY 4,650 million, operating profit of JPY 550 million, profit of JPY 380 million and basic earnings per share of JPY 13.23.
For the year, the company expects net sales of JPY 9,600 million, operating profit of JPY 1,300 million, profit of JPY 900 million and basic earnings per share of JPY 31.33.
DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Companyâs products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.